Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Pharma, biotech stocks topple on Trumps speech

      Pharma, biotech stocks topple on Trump's speech

      supriya kashyap kashyap13 Jan 2017 2:23 PM IST
      New York : Investors in large U.S. pharmaceutical and biotech companies are counting on strong dividends, reasonable stock valuations and new...
      Eli Lilly defeats Teva appeal over Alimta cancer drug

      Eli Lilly defeats Teva appeal over Alimta cancer drug

      supriya kashyap kashyap13 Jan 2017 2:17 PM IST
      A U.S. appeals court said Eli Lilly and Co may block Teva Pharmaceutical Industries Ltd from selling a generic equivalent of its top-selling lung...
      Aurobindo Pharma to buy Portugals Generis for 135 mn euro

      Aurobindo Pharma to buy Portugals Generis for 135 mn euro

      supriya kashyap kashyap9 Jan 2017 11:44 AM IST
      New Delhi : Aurobindo Pharma said it has inked a pact to acquire Portugal's Generis Farmaceutica SA from Magnum Capital Partners for a consideration...
      Indian startup launches wearable devices for fitness

      Indian startup launches wearable devices for fitness

      supriya kashyap kashyap9 Jan 2017 9:45 AM IST
      Washington : Aimed at changing the regular fitness regimes with a combination of new-age thinking and technology, an Indian startup has announced the...
      Novartis joins forces with Ionis on cardiovascular treatments

      Novartis joins forces with Ionis on cardiovascular treatments

      supriya kashyap kashyap8 Jan 2017 11:54 AM IST
      Novartis has agreed with Ionis Pharmaceuticals Inc and its affiliate Akcea Therapeutics Inc to license two experimental cardiovascular treatments in a...
      Synthetic Biologics C difficile mid-stage study meets main goal

      Synthetic Biologics C difficile mid-stage study meets main goal

      supriya kashyap kashyap8 Jan 2017 11:54 AM IST
      Synthetic Biologics Inc said its experimental treatment designed to reduce antibiotic-resistant "superbug" infections notably life-threatening C....
      Natco may launch leukaemia drug in US market by Nov 2019

      Natco may launch leukaemia drug in US market by Nov 2019

      supriya kashyap kashyap8 Jan 2017 11:51 AM IST
      Hyderabad : Natco Pharma Ltd said following the approval from US Food and Drug Administration for its generic version of Bendamustine Hydrochloride...
      Regeneron, Sanofi to appeal US judge ban on cholesterol drug sales

      Regeneron, Sanofi to appeal US judge ban on cholesterol drug sales

      supriya kashyap kashyap8 Jan 2017 11:51 AM IST
      Regeneron Pharmaceuticals Inc and Sanofi SA said they would appeal the U.S. District Court ruling which banned the two companies from selling their...
      Oxy Reckitt Benckiser ex-chief get 7 years in prison

      Oxy Reckitt Benckiser ex-chief get 7 years in prison

      supriya kashyap kashyap7 Jan 2017 11:51 AM IST
      Seoul : A South Korean court has sentenced the former head of Oxy Reckitt Benckiser to seven years in prison after the company's disinfectant for...
      Sanofi and Boehringer Ingelheim confirm Closing of business swap on January 1st 2017

      Sanofi and Boehringer Ingelheim confirm Closing of business swap on January 1st 2017

      supriya kashyap kashyap7 Jan 2017 11:45 AM IST
      Paris : Sanofi and Boehringer Ingelheim confirmed that the strategic transaction signed in June 2016, which consists of an exchange of Sanofi’s...
      Glenmark Pharmaceuticals Receives FDA Clearance of IND for GBR 1302-BEAT Phase I Trial

      Glenmark Pharmaceuticals Receives FDA Clearance of IND for GBR 1302-BEAT Phase I Trial

      supriya kashyap kashyap7 Jan 2017 11:45 AM IST
      Mahwah : Glenmark Pharmaceuticals, a global pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) cleared the Company's...
      Practo Ray Tab Introduces Digital Consent Forms for the first time in India

      Practo Ray Tab Introduces Digital Consent Forms for the first time in India

      supriya kashyap kashyap7 Jan 2017 11:45 AM IST
      Bangalore : Practo, the leading digital healthcare platform has announced the integration of consent forms into the Practo Ray Tab for the first time....
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok